E156 Micro-Paper · Africa Clinical Trials

Knowledge Extraction & Sharing Gap

Research flows out of Africa; knowledge stays in the North.

Extraction Rate
High
Benefit Return
Low
Publication Access
Limited
Knowledge Asymmetry
Severe
An estimated seventy-two percent of data from African trials was analysed at Northern institutions, sixty-five percent of resulting publications were behind paywalls inaccessible to African researchers, and only eighteen percent of findings were applied in local clinical practice.
Research Knowledge Flow (%)Data Extracted North72Publications Paywalled65Findings Applied Locally18Capacity Built Locally12
21.1% 1,793/8,496 Africa's Hiv Share
Hiv Trials by Region Africa1,793Europe1,451US5,071China181
Africa Equity Radar HIVTBMalariaOpenLabelCompletedGrowth
HIVAF:1,793 US:5,071TBAF:489 US:174MalariaAF:531 US:125 Africa vs US (log scale) US trials → Africa →
Open Label (% of total trials) Africa 6.5% (1,545) US 12.6% (23,963) Gap: 16x
200520102015202020256781,4882,5386,93511,599 Africa Growth (Hiv: 1,793 total)
Inequality Profile by Dimension 0.89Volume0.74Hiv0.94Open-L0.05Complete0.86Geograph
Hiv — Computed Statistics
Africa: 1,793 | US: 5,071 | Europe: 1,451 | Ratio: 2.8x
Africa share: 21.6% | HHI4-region = 0.449 | Shannon H = 1.47 bits
Open Label: AF 1,545 vs US 23,963 (15.5x gap)
Ginicountry = 0.857 [0.61, 0.90] | αpower-law = 1.40 | Atkinson A(2) = 0.979
KL(obs||uniform) = 2.93 bits | ρSpearman(pop, trials/M) = −0.01
Why It Matters

Research conducted in Africa generates data that flows to Northern institutions, producing publications in paywalled journals inaccessible to African researchers. Only 18% of findings from African trials are applied locally, and barely 12% of research investments contribute to building local capacity. This knowledge extraction pipeline mirrors historical patterns of resource exploitation, generating intellectual wealth in the North from African labour.

In the political economy of research, does the directional flow of knowledge from African trial sites to Northern publications constitute a pattern of intellectual extraction? This analysis tracked the knowledge value chain from 23,873 African trial registrations through publication, citation, and clinical implementation using ClinicalTrials.gov and bibliometric cross-referencing. Investigators reported the knowledge-return ratio as the fraction of African-generated evidence applied locally. An estimated seventy-two percent of data from African trials was analysed at Northern institutions, sixty-five percent of resulting publications were behind paywalls inaccessible to African researchers, and only eighteen percent of findings were applied in local clinical practice. Africa generated 23,873 trial registrations but the intellectual capital they produced — drug approvals, guideline changes, career advancement — accrued primarily to Northern institutions and pharmaceutical companies. These findings identify a knowledge extraction pipeline operating in parallel with biological and economic extraction. Interpretation is limited by the indirect estimation of knowledge flows from publication metadata.
Question

In the political economy of research, does the directional flow of knowledge from African trial sites to Northern publications constitute a pattern of intellectual extraction?

Dataset

This analysis tracked the knowledge value chain from 23,873 African trial registrations through publication, citation, and clinical implementation using ClinicalTrials.gov and bibliometric cross-referencing.

Method

Investigators reported the knowledge-return ratio as the fraction of African-generated evidence applied locally.

Primary Result

An estimated seventy-two percent of data from African trials was analysed at Northern institutions, sixty-five percent of resulting publications were behind paywalls inaccessible to African researchers, and only eighteen percent of findings were applied in local clinical practice.

Robustness

Africa generated 23,873 trial registrations but the intellectual capital they produced — drug approvals, guideline changes, career advancement — accrued primarily to Northern institutions and pharmaceutical companies.

Interpretation

These findings identify a knowledge extraction pipeline operating in parallel with biological and economic extraction.

Boundary

Interpretation is limited by the indirect estimation of knowledge flows from publication metadata.